TruthArchive.ai - Related Video Feed

The discussion centers on concerns and policy questions regarding pediatric vaccines, their safety, and how authorities respond to families who choose not to vaccinate. Key points raised by Speaker 0: - Pediatric vaccination schedules are increasing, with currently up to about 30 doses from birth to 2 years. Some vaccines, such as the hepatitis B vaccine, the acellular pertussis (3-in-1) vaccine, and the influenza vaccine given after 6 months, contain additives such as thiomersal (mercury-containing compound) and aluminum adjuvants. There is worry among some about potential long-term effects on brain development from thiomersal and other additives. - Thiomersal in vaccines is described as an organomercury compound that decomposes to ethyl mercury; historical notes are given about its association, in some sources, with developmental disorders in the 1990s, and there is reference to materials from the Ministry of Health, Labour and Welfare explaining its presence in certain vaccines and associated documentation. - The vaccine components discussed include thiomersal in current hepatitis B vaccines (e.g., Belcevir or Veemegen trade names), and aluminum-containing compounds in combination vaccines and the cervical cancer vaccine (HPV). There are concerns about neurotoxicity and memory impairment reported in some sources, and questions are raised about how these substances are evaluated in light of pediatric metabolism and excretion. - The text also points to broader concerns about modern additives in foods (artificial sweeteners, neonicotinoids, tar dyes) as part of a context for questioning vaccine safety, though the central focus remains vaccines and their additives. Speaker 0 also emphasizes a paradox: despite declining birth rates, the number of children with developmental disorders such as ADHD, autism spectrum disorders, and learning disabilities has risen, leading to heightened parental anxiety about early vaccination (birth to 2 months). The speaker highlights that even if experts claim the amounts are tiny, parents’ concerns persist. A call is made to present attached documentation and graphs to explain these points, as well as the overall safety profile. Questions and responses about policy and practice: - Speaker 1 explains preventive vaccination law (Article 8 and 9) authorizing municipalities to issue guidance and reminder notices for vaccinations, including vaccines against measles, rubella (MR), HPV, and Japanese encephalitis (the latter appears in the discussion as often related to catch-up schedules). The notices are for encouragement, not coercive mandates. - On the issue of refusals and potential neglect: it is stated that vaccinating of unvaccinated children is not, by itself, considered neglect; the decision to not vaccinate does not automatically constitute abuse or neglect. The speaker emphasizes that the question is about ensuring access to vaccination information and avoiding punitive labeling. - The role of childcare facilities and schools: there is discussion about whether vaccination status affects eligibility or admission. It is clarified that vaccination history is part of health records but does not automatically disadvantage a child in admission processes. Authorities acknowledge that some educators may view non-vaccination as neglect, and there is a preference to improve information sharing and awareness so that staff understand vaccination matters without stigmatizing families. - The need for uniform understanding among healthcare workers and educators is stressed. It is suggested that vaccination-related information be shared between childcare, school administration, and health departments to minimize misunderstandings and to ensure equitable treatment. - There is acknowledgement of concerns about social attitudes toward families who opt out of vaccination, and a call to respect differing judgments while improving communication and education among professionals. Speaker 3 and 4 contribute: - They reiterate that in childcare settings, health screening and eligibility processes may consider vaccination history, but not in a way that inherently disfavors unvaccinated children. They also address the possibility of attitudes among staff about neglect, noting a need for consistent information, training, and collaboration to reduce stigma. - A broader aim is expressed: foster a society where mutual respect for different vaccination decisions is possible, supported by clear communication and shared information among healthcare providers and educators. Overall, the discussion distinguishes between official guidance and punitive actions, reinforces that unvaccinated status alone is not treated as neglect, and calls for better information-sharing and supportive responses to families navigating vaccination decisions.

Speaker 0 suggests giving a child who hasn't received any immunizations before six different injections at once. Speaker 1 confirms that a six-month-old would receive DTaP, polio, and Hep B vaccines. They discuss the use of aluminum adjuvants in vaccines to make them more effective. Speaker 1 asks about the form of aluminum used in vaccines, and Speaker 0 mentions that ingested aluminum is different from injected aluminum. They discuss the safety of injected aluminum and its ability to cross the blood-brain barrier. Speaker 1 asks about antigens bound to aluminum and their role in creating antibodies. They also mention the presence of animal and human parts in vaccines. Speaker 0 is unsure about the specific details. They discuss the use of aborted fetal tissue in vaccine production and the presence of cellular debris in vaccines. Speaker 0 relies on CDC and American Academy of Pediatrics recommendations for vaccine safety. They consider family history factors, such as immune suppression, when determining vaccine recommendations. They clarify the type of polio vaccine used in the United States.

"This vaccine has six vaccines in one." "epinephrine and other appropriate agents and equipment must be available for immediate use if you're going to be giving this vaccination." "This vaccine is indicated for six weeks old through four years old." "a review by the Institute of Medicine found evidence for a causal, not correlation, causal relationship between tetanus toxoid, one of the components, and both brachial neuritis and Guillain Barre syndrome." "apnea, that's difficulty breathing, you kinda stop breathing, following intramuscular vaccination has been observed in some infants." "there is not a single randomized controlled study with an inert placebo. It's only tested against other vaccinations." "Three hundred nineteen micrograms of aluminum is used as an adjuvant." "Vaxelis has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility."

The speaker discusses the Vaxelis vaccine, a six-in-one vaccine for children aged six weeks to four years, protecting against diphtheria, tetanus, pertussis, polio, Haemophilus B, and hepatitis B. The speaker references the package insert, noting epinephrine and other agents should be available during administration. The speaker highlights a review by the Institute of Medicine that found a causal relationship between tetanus toxoid and both brachial neuritis and Guillain Barre syndrome, a type of paralysis. Apnea following intramuscular vaccination has been observed in some infants. The speaker claims there were no randomized controlled studies with an inert placebo during the vaccine's development, only tests against other vaccinations. Ingredients include aluminum, formaldehyde, bovine serum albumin, neomycin, Streptomycin, and Polymyxin B. The speaker points out that Vaxelis has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility.

The speaker believes all vaccines are suspect. As an emergency medicine physician, the speaker thought vaccines only contained a dead or attenuated virus and saline. In September 2000, after reading a package insert and researching vaccines, the speaker was mortified to learn that a child receiving all scheduled vaccines gets almost 13,000 micrograms of aluminum, almost 600 micrograms of mercury, and over 200 chemicals. The speaker states that this is why vaccines have never been proven safe, and vaccination is like injecting foreign matter into a baby.

This is the current CDC recommendations for vaccines for children. On day number one, they get their first jab, a hepatitis vaccine. By the time they're 18, they've had 18 jabs. By the time they get to build up to vote, they have 76 jabs. Speaker 0 discusses vaccines and a timeline from birth to adulthood milestones. These lines illustrate a staged vaccination pattern culminating in 76 jabs. However, the transcript includes no further detail about the vaccines, dosing intervals, or specific ages beyond 18. The overall message emphasizes a count of injections rather than the nature of each vaccine.

The speaker discusses the American Academy of Pediatrics' recommendation to ban all vaccine exemptions, noting that 50% of pediatricians' revenue comes from well-child check vaccine schedules. The speaker focuses on the Vaxelis vaccine by Merck, a six-in-one vaccine for children aged six weeks to four years, containing diphtheria, tetanus, pertussis, polio, haemophilus B, and hepatitis B. The speaker highlights that the Institutes of Medicine found a causal relationship between Vaxelis and Guillain Barre syndrome. Each dose contains 319 micrograms of aluminum, formaldehyde, bovine serum albumin, and antibiotics like neomycin, streptomycin, and polymyxin B. The speaker points out that Vaxelis has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility.

A speaker is sharing information about the Vaxelis vaccine, referencing the package insert. The vaccine is a six-in-one shot for diphtheria, tetanus, pertussis, polio, haemophilus b, and hepatitis b, indicated for children six weeks to four years old. The speaker notes epinephrine and other equipment must be available during vaccination. The Institute of Medicine found a causal relationship between tetanus toxoid and brachial neuritis and Guillain Barre syndrome. Apnea has been observed in some infants after intramuscular vaccination. The speaker claims there were no randomized controlled studies with an inert placebo, only tests against other vaccines. Ingredients include 319 micrograms of aluminum, formaldehyde, bovine serum albumin, neomycin, streptomycin, and polymyxin b. The speaker points out that Vaxelis has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility.

Speaker 0 suggests that a child who hasn't received any immunizations will have to endure six injections at once. Speaker 1 confirms that a six-month-old would receive DTaP, polio, and Hep B vaccines. Speaker 0 mentions that the type of Hep B vaccine depends on previous sessions. The same applies to a two-and-a-half-year-old. Speaker 1 questions why aluminum adjuvants are used in vaccines, to which Speaker 0 replies that they make the vaccine more effective. Speaker 1 asks about the form of aluminum and its effects, but Speaker 0 is unsure. They discuss the quantity of ingested and injected aluminum, but Speaker 0 believes the amount in vaccines is safe. Speaker 1 questions the ability of aluminum to cross the blood-brain barrier, but Speaker 0 is unaware. They also discuss antigens, macrophages, and vaccine ingredients, but Speaker 0 lacks specific knowledge. The conversation ends with Speaker 1 asking about family history factors and the type of polio vaccine used in the US. Speaker 0 provides some clarification.

Dr. Menares and an interlocutor debate the science behind pediatric COVID vaccination and routine immunizations, focusing on transmission, hospitalization, and risk. - The interlocutor asks whether the COVID vaccine prevents transmission. Speaker 1 answer: the vaccine can reduce viral load in individuals who are infected, and with reduced viral load, there is reduced transmission. The interlocutor reframes, insisting that the vaccine does not prevent transmission and notes decreasing effectiveness over time, citing Omicron data showing around 16% reduction when there is a reduction. - On hospitalization for children 18 and under: Speaker 0 asserts the vaccine does not reduce hospitalization for 18-year-olds; statistics are inconclusive due to small numbers of hospitalizations in that age group (approximately 76 million people aged 18 in the country, with 183 deaths and a few thousand hospitalizations in 2020–2021; numbers have since dropped). The argument emphasizes a need to discuss the issue. - On death for children 18 and under: Speaker 0 says the vaccine does not reduce the death rate; claims there is no statistical evidence that it reduces deaths. Speaker 1 responds with a more cautious stance: “It can,” but Speaker 0 counters, calling that an insufficient answer. - The discussion references the vaccine approval process and ongoing debates in vaccine committees. The interlocutor states that when the vaccine was approved for six months and older, the discussion acknowledged no proof of reduction in hospitalization or death. The argument asserts that the justification for vaccination is based on antibody generation rather than clear hospitalization/death data. The interlocutor contends that immunology measurements (antibody production) do not necessarily justify vaccination frequency. - The core debate centers on what the science supports for vaccinating six-month-olds and the benefits versus risks. The interlocutor argues there is no hospitalization or death benefit for vaccination in this age group, and notes a known risk of myocarditis in younger populations, estimated somewhere between six and ten per ten thousand, which the interlocutor claims is greater than the risk of hospitalization or death being measurable. - The exchange then shifts to changing the childhood vaccine schedule, particularly the hepatitis B vaccine given to newborns when the mother is not hepatitis B positive. The interlocutor asks for the medical or scientific reason to give a hepatitis B vaccine to a newborn with an uninfected mother, arguing that the discussion should focus on whether to change the schedule rather than declaring all vaccines as good or bad. - Speaker 1 says they agreed with considering the science and would not pre-commit to approving all ACIP recommendations without the science. Speaker 0 disagrees, asserting their position that the debate should center on the medical rationale for these specific vaccines and schedules, not on a blanket endorsement of vaccines. - Throughout, the dialogue emphasizes examining the medical reasons and evidence for specific vaccines and schedules, rather than broad generalizations about vaccines.

Hepatitis B is contracted through sexual activity and IV drug use. The speaker believes babies do not need the hepatitis B vaccine. The hepatitis B vaccine contains 250 micrograms of aluminum. The speaker states that after Thimerosal was removed from vaccines, the hepatitis B vaccine was moved from being given to teenagers to newborns. The speaker claims the amount of aluminum in the vaccine is five times the adult daily maximum.

Pediatricians recommend getting both the valent and neococcal vaccines within the first three months of a baby's life. However, there are concerns about potential neurological damage and permanent effects. The incidence of these issues is not clear, as reactions are often not recognized or attributed to something else. Some children have experienced serious problems, including autism, which some believe is correlated with vaccines. However, the scientific community has dismissed this correlation. Vaccines have been crucial in eradicating diseases like polio, and without them, these diseases could resurface. The safety and effectiveness of vaccines are supported by numerous studies, although some claim they can cause tumors and other health issues.

The speaker discusses a recommendation from the American Academy of Pediatrics to ban all vaccine exemptions, noting that 50% of pediatricians' revenue comes from well-child check vaccine schedules. The speaker focuses on the Vaxelis vaccine by Merck, a six-in-one vaccine for children aged six weeks to four years, protecting against diphtheria, tetanus, pertussis, polio, haemophilus B, and hepatitis B. The speaker highlights that the Institutes of Medicine found evidence for a causal relationship between Vaxelis and Guillain Barre syndrome. Each dose contains 319 micrograms of aluminum, formaldehyde, bovine serum albumin, and antibiotics like neomycin, streptomycin, and polymyxin B. The speaker points out that Vaxelis has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility.

Here's something that people should know, is that aluminum provokes an allergic response, and that's why it's valuable. So if you put the aluminum in with the viral antigen, your body now mounts an allergic response to that viral antigen, whether it's polio or hepatitis B or the, you know, HPV or whatever. the alumina also creates allergic responses to anything that's in the ambient environment. So if you have a peanut oil excipient in that vaccine, you and you put aluminum in it, now you could have a lifetime allergy to peanuts. And, you know, there’s two studies by Mawson and Cowlings, which show that children who are vaccinated with aluminum vaccines have thirty times the rate of allergic rhinitis as kids who don't.

The speaker discusses the Vaxelis vaccine, a six-in-one vaccine for children aged six weeks to four years, protecting against diphtheria, tetanus, pertussis, polio, Haemophilus B, and hepatitis B. The speaker notes the package insert states epinephrine and other agents must be available during vaccination. They highlight a review by the Institute of Medicine found a causal relationship between tetanus toxoid and both brachial neuritis and Guillain Barre syndrome, a type of paralysis. Apnea following intramuscular vaccination has been observed in some infants. The speaker claims there were no randomized controlled studies with an inert placebo, only tests against other vaccines. Ingredients include aluminum, formaldehyde, bovine serum albumin, neomycin, Streptomycin, and Polymyxin B. The speaker points out Vaxelis has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility.

The speaker claims the six-month well baby visit is the most dangerous because babies get 10 vaccines at once. The newborn Hep B vaccine contains a dangerous form of aluminum. The one-year or 15-month visit is also risky due to the MMR vaccine's "undeniable" relationship to autism. At that visit, children may also receive chicken pox, Hep B, Prevnar, Tdap, COVID, and flu shots. The MMR and chickenpox vaccines contain four live viruses, which is a high risk for seizures. The speaker alleges vaccines load children with aluminum, creating inflammation, leaky gut, and leaky brain. Giving live viruses to children in this state causes brain inflammation and regression into autism. The vaccine schedule is a disaster and has never been studied in its entirety. Individual vaccines have not been studied with a proper placebo and only look at short-term side effects.

We couldn't find any prelicensing safety trials for the 72 vaccines doses that are recommended for American children. Unlike other medications, vaccines were exempt from conducting safety trials that compare health outcomes between a placebo group and a vaccine group. This lack of safety trials is concerning considering the widespread use of these vaccines.

The childhood vaccine schedule is managed by a vaccine advisory group with CDC and American Academy of Pediatrics representation. Changes would come to my desk for review, but this committee is very influential in vaccine policy. Regarding the hepatitis B vaccine, I'm surprised it's given to day-old babies based on limited safety data from a study with only a five-day review period and no placebo group. The FDA likely extrapolated adult data, but I don't think this establishes safety for newborns. I would prefer to see this vaccine given to older children. I disagree with the heavy-handed approach to vaccines, as it increases hesitancy and distrust. Doctors should educate, not badger or threaten, people about vaccines. I'm not a big advocate for one-year-olds getting the hepatitis B vaccine unless the mother is hepatitis B positive and the baby is at high risk.

We couldn't find a prelicensing safety trial for any of the 72 vaccines doses recommended for American children. Unlike other medications, vaccines were exempt from conducting safety trials that compare health outcomes between a placebo group and a vaccine group.

Pentacel is five in one vaccination by Sanofi Pasteur. It covers diphtheria, tetanus, pertussis, polio, Hib, indicated for six weeks through four years, with four doses at two, four, six months, and between fifteen and eighteen months. Section five warns: Guillain Barre syndrome; a review by the Institutes of Medicine found evidence of a causal relationship between this vaccine and Guillain Barre syndrome. It contains one point five milligrams of aluminum phosphate as an adjuvant, polysorbate eighty, residual formaldehyde, bovine serum albumin, streptomycin, neomycin, polymyxin B. All this in a two month old. Pentacel has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility. Translation. We don't know if this vaccine could lead to cancer or impair this child's ability with fertility later in life.

Big problem with trusting the science is not the science part, it's who's behind the science part, primarily in the area of vaccines for children. Normally, when you study a drug, you compare it with a placebo, so that way you can truly test the side effects on something, but that is not how they test children's vaccines. This so called placebo control is not really a true placebo control because it's not inert. It's an active vaccine with something called an adjuvant. The big one that they've been using for a long time is aluminum. My question is, how can you really truly test the safety and effectiveness of something if you're looking at the relative safety of an active vaccine to another active vaccine with adjuvants. That just muddies the water to this whole safe and effective claim that you keep hearing over and over and over.

"Parents should really stick the course and make sure that their children get all of the routine childhood vaccinations." "The American Academy for Pediatrics has reaffirmed that infants, children between the ages of six months and two years should get their COVID shots." "The first encounter with COVID should be with the shot, not with the virus." "There is still a very high risk in younger children, particularly six months to two years for hospitalization and severe complications if they get COVID." "And pregnant women should be getting the COVID vaccine." "Routine childhood vaccines have actually been thimerosal free for years now." "Aluminum nudges the immune system so that you get a longer lasting, more robust immune response with fewer doses." "There's no evidence that it's harmful." "There is a very strong track record of vaccines in randomized placebo controlled trials."

Here's something that people should know, is that aluminum provokes an allergic response, and that's why it's valuable. So if you put the aluminum in with the viral antigen, your body now mounts an allergic response to that viral antigen, whether it's polio or hepatitis B or the, you know, HPV or whatever. So if you have a peanut oil excipient in that vaccine, you and you put aluminum in it, now you could have a lifetime allergy to peanuts. They take the aluminum adjuvant from the hepatitis B vaccine, add a latex molecule, and that rat now has a permanent latex allergy. You add a peanut molecule and it has a permanent peanut allergy.

Morning message, Friday, August 1, informed consent Friday. The American Academy of Pediatrics came out with a recommendation that we ban all vaccine exemptions. The revenue note: 50% of the revenue of most pediatricians occur as a result of the well child check vaccine schedule. Merck's Vaxelis, six in one. Diphtheria, tetanus, pertussis, polio, haemophilus b, and hepatitis b. That's six, indicated for children starting from six weeks to four years old. Section 5.3, a review by the Institutes of Medicine found evidence for a causal not correlation, but causation relationship between this vaccine and Guillain Barre syndrome. Section 11, what are the ingredients? Well, each dose contains three hundred and nineteen micrograms of aluminum from aluminum salt used as adjuvants. Section 13.1. Quote, Vaxelis has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility. Informed consent. Vaxilus.

The discussion centers on pediatric vaccination, concerns about vaccine additives, and the policies around notifying and handling families who choose not to vaccinate. Key points raised about vaccines and additives - The number and type of pediatric vaccines have increased over the years, with regular vaccination schedules extending up to 30 doses from birth. Some vaccines, such as certain hepatitis B vaccines, the 3-valuent (3-in-1) vaccine, and post-6-month optional influenza vaccines, contain thimerosal (mercury-containing preservative) and/or other additives that provoke worry about brain impact or cancer risk. - Thimerosal is discussed as an organomercury compound that decomposes to ethyl silver in the body; it is described as having been linked to developmental disorders in the 1990s, with references to documents from Materials Supplemental 1 and 3, and to B-type hepatitis vaccines (e.g., a product branded as Beemgen) containing thimerosal and organo-silver components. - The discussion notes aluminum compounds in some vaccines (with two types in the quadrivalent types and in the cervical cancer vaccine) and mentions concerns about aging-related memory impairment (Alzheimer’s risks) associated with aluminum compounds. - Influenza vaccines, including those supplied post-6 months, are described as containing both thimerosal and chloromethyl sulfone-like additives (referred to as chelators/a set). The quadri- and other mixed vaccines are noted to include thimerosal and aluminum compounds; the cervical cancer vaccine is noted to contain aluminum compounds as well as thymus-specified adjuvants. - There is a broader perspective linking neurotoxins in vaccines to concerns about developmental disorders (ADHD, autism spectrum, learning disorders, emotional instability) and general caution about late-emerging effects. The panel emphasizes that even if expert explanations claim trace, minimal quantities do not reassure all caregivers given rising rates of developmental issues despite fewer births. Observations on public health trends and caller concerns - The panel highlights a marked rise in developmental disorders (ADHD, autism, learning disorders, emotional instability) among children after a period when these categories expanded, juxtaposed with a decreasing birth cohort, implying a seemingly paradoxical upward trend when viewed by percentage. - General concerns extend beyond vaccines to other substances in the modern environment (artificial sweeteners, residual pesticides like neonicotinoids, artificial colorings) as potential public health risks. Responses and policy points from officials - The formal framework: Routine vaccination is a matter of public health policy; the Vaccination Act provisions empower municipalities to issue notifications and encourage vaccination, but the notifications are not coercive mandates. Vaccination reminders for vaccines like MMR, HPV, and Japanese-origin vaccines are described as communications to encourage uptake rather than punitive actions. - If a caregiver declines vaccination, it is stated that this alone does not constitute abuse or neglect, and refusal to vaccinate is not treated as neglect in determining child welfare. The responses emphasize that “prevention vaccination being unvaccinated” should not automatically trigger neglect findings. - The panel distinguishes between a notification (intervention to promote vaccination) and a neglect finding; it is stated that unvaccinated status alone does not automatically lead to neglect designation. - There is emphasis on informing and sharing information among healthcare providers, educational staff, and child-care settings to ensure consistent understanding that vaccination status is not equivalent to parental neglect. There is a call for standardized awareness within healthcare, child-care, and school administrations. - Questions also address administrative processes: whether vaccination history must be included in the Health Liaison form used during daycare enrollment, and whether non-vaccinating caregivers should be labeled as negligent. Officials indicate that vaccination history should be recorded but that lack of vaccination should not penalize enrollment; information sharing across child-care and school systems should be possible to reduce stigma. - The dialogue includes concerns about the attitudes of some caregivers and teachers who may perceive non-vaccination as laziness; officials stress reducing such misconceptions and promoting respectful, informed decision-making. Concluding remarks from the speakers - The dialogue clarifies the difference between interference/consultation (干渉通知) and formal seeking of consent (勧告) for vaccination, and confirms that neglect findings should not be based solely on non-vaccination. The speakers express an intention to promote accurate, balanced information and to reduce stigma around families who choose not to vaccinate, while continuing to encourage vaccination as a public health measure.